Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Feb 24, 2022
Webinar - Spray Drying Development: From Lab to Production – How to de-risk your process
Read more
Scientific Article
/ Feb 28, 2023
Webinar - Amorphous Solid Dispersions by Spray Drying: From Early Formulation to Commercial Lifecycle Management
Read more
Scientific Article
Scientific Article